Instituto Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa – Portugal
Luísa V. Lopes is a Group leader Instituto de Medicina Molecular (iMM Lisboa, Portugal).
Her current work focuses on understanding the mechanisms inducing the "early-aging" of the cognitive function. Her lab has provided evidence for an important contribution of adenosine receptors in pathophysiological context, and their impact in noxious brain conditions such as stress, aging and neurodegeneration, being awarded by FEBS, FENS and EMBO.
Luisa established her own research group@iMM in 2013, as recipient of an Investigator FCT position.
Her contribution includes providing the crucial first evidence of a possible glucocorticoid - adenosine link in Alzheimer’s disease (with D. Blum); following previous groundwork suggesting circadian disorders as a trigger for accelerated cognitive loss.
She has authored more than 50 papers in international peer-reviewed journals with over 1000 citations. These include top journals in the field of neuroscience, such as Nature Neuroscience, Molecular Psychiatry, Journal of Neuroscience, as a senior author; including an award publication in TINS.
Luisa served as a Board Member of Portuguese Society for Neuroscience (2008-2011) and got an award from DANA Alliance for her work in raising public awareness for brain research.